SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-054312
Filing Date
2024-03-01
Accepted
2024-03-01 06:06:02
Documents
17
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d781057d8k.htm   iXBRL 8-K 25216
2 EX-99.1 d781057dex991.htm EX-99.1 120328
3 EX-99.2 d781057dex992.htm EX-99.2 80002
7 GRAPHIC g781057snap1.jpg GRAPHIC 706
  Complete submission text file 0001193125-24-054312.txt   378100

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctkb-20240228.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctkb-20240228_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctkb-20240228_pre.xml EX-101.PRE 10806
18 EXTRACTED XBRL INSTANCE DOCUMENT d781057d8k_htm.xml XML 3505
Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Filer) CIK: 0001831915 (see all company filings)

IRS No.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40632 | Film No.: 24706725
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)